Prof. Rolf Hartmann, Ph.D., Founder and Managing Director

Dr. Rolf Hartmann is Professor of Pharmaceutical and Medicinal Chemistry at the University of the Saarland, Saarbruecken, Germany. He is a referee of the Deutsche Forschungsgemeinschaft and the Editor-in-Chief of "Archiv der Pharmazie - Journal of Pharmaceutical and Medicinal Chemistry". His research work focuses on medicinal chemistry, drug design, biochemistry and in vivo pharmacology. A list of his publications can be found .


Dr. Chris J. van Koppen, Head of Research

Dr. Chris J. van Koppen holds a Ph.D. in Pharmacology and brings extensive industry experience in drug discovery. Before joining ElexoPharm in January 2012, he served as Leader of four lead optimization projects at Merck Sharp & Dohme (Netherlands). He was responsible for delivery of candidate drugs for preclinical development in endocrinological diseases. Dr. van Koppen was also strongly involved in assay development, HTS, lead finding and proof-of-concept projects. Before working at MSD, Dr. van Koppen was independent group leader at the Universit√§tsklinikum Essen and received his Habilitation in Pharmacology and Toxicology. He has published almost 70 peer-reviewed research papers, including publications in high IF journals. At ElexoPharm he will lead the preclinical drug discovery projects and will build further alliances with other pharmaceutical companies.